PT  - JOURNAL ARTICLE
AU  - Pereira, Igor G.
AU  - Guerin, Joris M.
AU  - Silva Júnior, Andouglas G.
AU  - Distante, Cosimo
AU  - Garcia, Gabriel S.
AU  - Gonçalves, Luiz M. G.
TI  - Forecasting Covid-19 dynamics in Brazil: a data driven approach
AID  - 10.1101/2020.05.11.20098392
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.11.20098392
4099  - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098392.short
4100  - http://medrxiv.org/content/early/2020/05/18/2020.05.11.20098392.full
AB  - This paper has a twofold contribution. The first is a data driven approach for predicting the Covid-19 pandemic dynamics, based on data from more advanced countries. The second is to report and discuss the results obtained with this approach for Brazilian states, as of May 4th, 2020. We start by presenting preliminary results obtained by training an LSTM-SAE network, which are somewhat disappointing. Then, our main approach consists in an initial clustering of the world regions for which data is available and where the pandemic is at an advanced stage, based on a set of manually engineered features representing a country’s response to the early spread of the pandemic. A Modified Auto-Encoder network is then trained from these clusters and learns to predict future data for Brazilian states. These predictions are used to estimate important statistics about the disease, such as peaks. Finally, curve fitting is carried out on the predictions in order to find the distribution that best fits the outputs of the MAE, and to refine the estimates of the peaks of the pandemic. Results indicate that the pandemic is still growing in Brazil, with most states peaks of infection estimated between the 25th of April and the 19th of May 2020. Predicted numbers reach a total of 240 thousand infected Brazilians, distributed among the different states, with São Paulo leading with almost 65 thousand estimated, confirmed cases. The estimated end of the pandemics (with 97% of cases reaching an outcome) starts as of May 28th for some states and rests through August 14th, 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is supported by CAPES under research grant 001 and by CNPq, research sponsoring agencies from Brazil.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPredicted data for Brazil can be found at http://www.natalnet.br/covid http://www.natalnet.br/covid